Cannabix Provides Alternative to Costly Drug Detection Tactics
Ryan Allway
January 26th, 2015
News, Top Story
Most drivers are familiar with breathalyzer tests, which quickly and accurately determine how much alcohol someone has consumed. Originally developed in the 1930s, the device determines how much ethanol is in the breath by measuring the electrical current between an anode and cathode. Law enforcement agencies around the world now use the device as both a preliminary screening and evidentiary tool to prosecute drunk drivers.
With the legalization of medical and adult-use marijuana in the U.S. and Canada, there is a growing demand for a device capable of testing for drivers that are impaired by marijuana, more specifically “THC”. Law enforcement agencies have few tools at their disposal for detecting “high” drivers, with many agencies resorting to specialized police officer training programs. In many cases, a suspect that’s taken in for such an offense must undergo lengthy testing from a “DRE” (more on this below) then undergo blood tests to confirm.
In this article, we’ll take a look at the problems with the existing marijuana detection techniques and explore how one company is developing an innovative solution.
What’s the Legal Limit?
The legal limits for driving under the influence (“DUI”) for alcohol are well established throughout the country and around the world. If a driver tests above the legal limit, they are charged with a DUI and face penalties that vary by state and country. The legal limits for marijuana consumption – specifically THC, the psychoactive component of marijuana – are a lot less certain given the recency of legalization in many jurisdictions.
In Colorado and Washington State, where adult-use marijuana has been legalized for over a year, the legal limit for THC has been established at five or more nanograms per milliliter. Critics say that the level is unfair for marijuana users, since the drug metabolizes slowly and stays in the blood for a long time, while others argue that the blood or urine tests necessary to accurately measure THC are overly invasive to those who may not even be guilty.
There is also a lot of disagreement on what constitutes impairment when driving. While there’s little doubt that driving “high” is dangerous, as evidenced by numerous vehicular studies, the five nanogram per milliliter limit appears more of an arbitrary pick rather than a number rooted in science, according to advocacy organizations like NORML. Furthermore, organizations like the Institute for Behavior and Health (IBH) argue that the 5 ng/ml per se limit provides the appearance of protecting the public, but in reality it only protects marijuana users driving under the influence of marijuana from prosecution. Nearly all marijuana users test below 5 ng/ml of active THC in blood only a few hours after their last use. Because of the unavoidably long delay between arrest and blood collection, it is certain that THC concentrations were higher when these drivers were stopped for suspicion of drugged driving because of rapidly declining THC levels after marijuana use stops. Regulators across various states and countries will likely have to continue working to find the right legal limits over time as the debate has just started.
Drug Recognition & Testing
The single largest barrier in prosecuting those driving under the influence of marijuana is the testing process. Since the drug’s legalization is so recent, the process of determining if someone is likely “high” and quantitatively testing the “high” is inefficient, invasive, and even costly for many law enforcement agencies. The good news is that at least one company is getting close to completing development of an innovative solution to the problem.
Currently, U.S. law enforcement officials undergo a training program to become a Drug Recognition Expert (“DRE”). These DREs detect behavioral patterns and use roadside tests to determine if someone is likely “high” before subjecting them to definitive blood or urine test. In Canada, the government has spent hundreds of thousands of dollars sending law enforcement officials to the U.S. to become trained as DREs and have only arrested a handful of people.
In 2012, just 1,126 drug impairment charges were made against Canadian drivers compared to 60,000 charges for alcohol impaired drivers. These numbers are partly due to the fact that there are just 570 active-duty DREs in the country. The cost of training police officers to become DREs can be between $5,800 and $17,000 each in recent years, while the true effectiveness of the techniques leaves a lot of room for improvement.
A Marijuana Breathalyzer
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO) is a company developing a hand-held marijuana breathalyzer for law enforcement that will look to provide instantaneous results at road-side as to whether there is THC in a person’s system by way of breath testing. While the device remains in development, the company has been actively securing patents on the concepts and is working with a engineering firm to create the first prototypes, which could be used to test the efficacy and usability of the device.
The underlying research for breath testing for THC was originated at the Karolinska Institute in Sweden. In a 2010 paper published in the Journal of Analytical Toxicology, scientists described a method for determining the level of THC exhaled in breath. Cannabix has worked with this research to develop a device that can stand up to the rigors of police use in the field. It has done so by leveraging an experienced team of medical and business professionals.
Finally, the company’s management team is well-qualified to execute on its vision and bring the product to market. President Kal Malhi worked as a Canadian Mountie for a decade, spending several years in the drug investigation team. In 2011, he left the force to focus his efforts in the business world and partnered with Dr. Raj Attariwala, who has a doctorate in biomedical engineering and works as a radiologist and nuclear medicine physician.
Conclusions
There are many different opportunities for investors interested in the marijuana space, ranging from growing operations like Tweed Marijuana Inc. (OTC: TWMJF) (TSX-V: TWD) to vaporizer manufacturers like Vape Holdings Inc. (OTC: VAPE). With its modest market capitalization, ongoing development of its breathalyzer prototype, and experienced management team at the helm, investors may want to take a closer look at Cannabix Technologies.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Mojave Jane Brands Inc. is a Canadian-based cannabis sector brand and distribution company emerging as a true vertical integrator in California’s legal cannabis space serving recreational and wellness markets. The Company’s U.S. holdings are comprised of assets set up as a vertical stack including cultivation to scale, branding, packaging, manufacturing & processing, as well as, […]
Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
